Qing Zhai

机构：Wannan Medical College, Hebei Medical University, Shanghai Medical College of Fudan University, Hospital of Hebei Province, Fudan University Shanghai Cancer Center, Second Hospital of Hebei Medical University, Second Affiliated Hospital of Zhejiang University, First Affiliated Hospital of Wannan Medical College, Anhui Polytechnic University · ORCID：0000-0003-1967-6572

发表论文 77 篇 · 总被引 1256 次 · h-index 20

代表论文

• Safety of trastuzumab deruxtecan: A meta‐analysis and pharmacovigilance study (2022 · Journal of Clinical Pharmacy and Therapeutics · 被引 36)
• Application of AP-MALDI Imaging Mass Microscope for the Rapid Mapping of Imipramine, Chloroquine, and Their Metabolites in the Kidney and Brain of Wild-Type Mice (2022 · Pharmaceuticals · 被引 32)
• CDK4/6 inhibitors in drug-induced liver injury: a pharmacovigilance study of the FAERS database and analysis of the drug–gene interaction network (2024 · Frontiers in Pharmacology · 被引 21)
• UBL3 Interacts with Alpha-Synuclein in Cells and the Interaction Is Downregulated by the EGFR Pathway Inhibitor Osimertinib (2023 · Biomedicines · 被引 17)
• Endocannabinoid 2-Arachidonoylglycerol Levels in the Anterior Cingulate Cortex, Caudate Putamen, Nucleus Accumbens, and Piriform Cortex Were Upregulated by Chronic Restraint Stress (2023 · Cells · 被引 14)
• Ocular adverse events associated with BRAF and MEK inhibitor combination therapy: a pharmacovigilance disproportionality analysis of the FDA adverse event reporting system (2023 · Expert Opinion on Drug Safety · 被引 11)